Open-Label, Uncontrolled, Multicenter Phase 2 Study of Cisplatin and 5-Fu Combined With Nimotuzumab As First-Line Treatment in Patients With Untreated Metastatic Nasopharyngeal Carcinoma
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin; Fluorouracil
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 29 May 2015 Planned End Date changed from 1 Dec 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 29 May 2015 Planned primary completion date changed from 1 Dec 2012 to 1 Dec 2015 as reported by ClinicalTrials.gov record.